Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases

Imiquimod is a topical immune response modifier used to treat anogenital warts. Although considered a safe drug, mild to moderate local and systemic side-effects may occasionally occur. We report three cases of local and systemic adverse effects related to imiquimod, including one case that mimicked...

Full description

Saved in:
Bibliographic Details
Published in:International journal of STD & AIDS 2012-12, Vol.23 (12), p.909-910
Main Authors: Rosenblatt, A, De Campos Guidi, H G
Format: Article
Language:English
Subjects:
AIDS/HIV
Alphapapillomavirus - isolation & purification
Aminoquinolines - adverse effects
Aminoquinolines - therapeutic use
Antiviral Agents - adverse effects
Antiviral Agents - therapeutic use
Biological and medical sciences
Condylomata Acuminata - drug therapy
Condylomata Acuminata - virology
Epidemiology. Vaccinations
General aspects
Human viral diseases
Humans
Infectious diseases
Interferon Inducers - adverse effects
Interferon Inducers - therapeutic use
Male
Medical sciences
Middle Aged
Viral diseases
Viral diseases of the genital and urinary system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Imiquimod is a topical immune response modifier used to treat anogenital warts. Although considered a safe drug, mild to moderate local and systemic side-effects may occasionally occur. We report three cases of local and systemic adverse effects related to imiquimod, including one case that mimicked meningitis, which promptly resolved with drug cessation.
ISSN:0956-4624
1758-1052
DOI:10.1258/ijsa.2012.012076